1-(substituted phenyl)-5methyl2 - (1H) pyridone in the manufacture of medicaments for treating fibrosis in organs or tissues

Details for Australian Patent Application No. 2006233433 (hide)

Owner Xiangya Hospital of Central South University

Inventors Tao, Lijian; Hu, Gaoyun

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006233433

PCT Pub. Number WO2006/108354

Priority 200510031445.7 13.04.05 CN

Filing date 11 April 2006

Wipo publication date 19 October 2006

International Classifications

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/108354 Priority application(s): WO2006/108354

22 November 2007 Amendment Made

  The nature of the amendment is: Add co-inventor Shi, Yuenian Eric

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233435-Human waste automatic processor

2006233359-Reducing levels of nicotinic alkaloids in plants